October 3, 2026
Adapting Eye Exams for Neurodivergent Patients
Adaptations can maintain diagnostic validity when sensory, communication, or executive-function barriers interfere with conventional methods.
American Academy of Optometry Annual Meeting 2026
Related Content
October 3, 2026
What Visual Hallucinations and Illusions Can Tell ODs About Low Vision
For optometrists, the phenomena discussed in the session provide additional context for patient reports that may initially appear inconsistent with conventional acuity and visual field findings.
October 2, 2026
When Retinal Findings Point to a Vascular Emergency
How to respond to high blood pressure, Hollenhorst plaques, and other vascular findings.
October 2, 2026
Looking Beyond the Eye Exam in Geriatric Eye Care
Four cases demonstrate an interdisciplinary approach to evaluating and managing older patients and their eye care.
October 2, 2026
The OD’s Guide to Cosmetic Oculoplastics
How to counsel patients with cosmetic ocular concerns
October 2, 2026
Addressing the Unanswered Questions in Myopia Management
What ODs need to know regarding ideal candidates, comparing efficacy, gauging success, and adult myopia.
October 2, 2026
Opportunities and Risks of Clinical AI
Artificial intelligence can help identify patterns and streamline routine tasks, but clinical judgment remains the foundation of patient care
October 1, 2026
Optometrists’ Role in Retinal Care in the Anti-VEGF Era
Referral shouldn't mean goodbye: Roya Attar, OD, MBA, DHA's clinical pearls for comanaging nAMD, DME, RVO, and more with retina specialists.
October 1, 2026
Remote Optometry Delivers, But Challenges Remain
Virtual eye exams boost access and speed, but gaps in referrals and follow-up care persist, explained Dr. Molly King in her presentation at the 2026 meeting of the American Academy of Optometry.
October 1, 2026
Topical Solutions for Presbyopia
A look at current treatments and a late-stage pipeline candidate for presbyopic patients
October 1, 2026
Beyond Amblyopia
A lack of expected improvement can provide an important clue that something more is affecting vision.
October 1, 2026
ATSN-201 Gene Therapy Shows Improvement in XLRS at 18 Months
Atsena Therapeutics reported data from the LIGHTHOUSE trial at the 2026 American Academy of Optometry meeting.
September 30, 2026
Geographic Atrophy Care in 2026
A look at progression predictors, emerging therapies, and how AI could change GA care
September 30, 2026
Launching a Successful Low Vision Practice
Practical advice for new doctors and optometry students on managing a low vision practice.
September 30, 2026
The Keratoconus Contact Lens Toolbox
Five contact lens modalities give practitioners options for addressing the varied visual and anatomical challenges of keratoconus.
September 30, 2026
Clues It May Not Be Glaucoma
Recognizing patterns that fall outside the typical glaucoma presentation can help clinicians identify other optic nerve and retinal disorders.